Nuclivision
PrivateLast Round
Seed
Apr 24, 2025
Total Funding Raised
$5.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nuclivision is a healthtech company that develops AI-powered software, Nuclarity, designed to enhance PET imaging by reducing scan times and radiation exposure.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuclivision Comparables
Compare Nuclivision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Claritas HealthTech | 30% |
Nuclivision Funding Rounds
Historical fundraising activity
Nuclivision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LUMO Labs | Seed |
| imec.istart | Pre Seed |
| HERAN Partners | Seed |
| Imec.iStart | Seed |
| Lumiares | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles increased to 21, 95% of headcount.
- Jul 13, 2026
Open roles increased to 14, 2.5x the trailing average.
Nuclivision Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nuclivision's valuation, stock price, and market status.
Is Nuclivision a public or private company?
Nuclivision is a private company.
What is the current stock price of Nuclivision?
Nuclivision is a private company, so its shares have no public market price. Caplight tracks Nuclivision's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nuclivision worth (valuation)?
Valuation information for Nuclivision is not publicly available.
Can I buy Nuclivision stock?
Nuclivision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nuclivision's last funding round?
Nuclivision's most recent funding round was Seed on April 24, 2025.
Who are the main investors in Nuclivision?
Key investors in Nuclivision include LUMO Labs, HERAN Partners.
Will Nuclivision IPO soon?
No public IPO plans have been announced for Nuclivision.
How can I track Nuclivision secondary market activity?
Caplight tracks bids, offers, and trades in Nuclivision's shares on secondary markets.